Agustí A - Search Results

1

Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United States.

Iglesias-Lopez C, Obach M, Vallano A, Agustí A. Iglesias-Lopez C, et al. Among authors: agusti a. Cytotherapy. 2021 Mar;23(3):261-274. doi: 10.1016/j.jcyt.2020.11.008. Epub 2021 Jan 19. Cytotherapy. 2021. PMID: 33483292

2

[Research on drug utilization in primary health care in national journals].

Arnau JM, Vallano A, Artigas R, Vallés JA, Agustí A, Colomé E, Pontes C, Diogene E. Arnau JM, et al. Among authors: agusti a. Aten Primaria. 1991 Dec;8(11):932-6. Aten Primaria. 1991. PMID: 1807427 Spanish.

3

Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital.

Vallano A, Cereza G, Pedròs C, Agustí A, Danés I, Aguilera C, Arnau JM. Vallano A, et al. Among authors: agusti a. Br J Clin Pharmacol. 2005 Dec;60(6):653-8. doi: 10.1111/j.1365-2125.2005.02504.x. Br J Clin Pharmacol. 2005. PMID: 16305591 Free PMC article.

4

Effect of an intervention on the features of adverse drug reactions spontaneously reported in a hospital.

Cereza G, Agustí A, Pedrós C, Vallano A, Aguilera C, Danés I, Vidal X, Arnau JM. Cereza G, et al. Among authors: agusti a. Eur J Clin Pharmacol. 2010 Sep;66(9):937-45. doi: 10.1007/s00228-010-0856-8. Epub 2010 Jun 16. Eur J Clin Pharmacol. 2010. PMID: 20552176

5

Educational sessions in pharmacovigilance: What do the doctors think?

Vallano A, Pedrós C, Agustí A, Cereza G, Danés I, Aguilera C, Arnau JM. Vallano A, et al. Among authors: agusti a. BMC Res Notes. 2010 Nov 17;3:311. doi: 10.1186/1756-0500-3-311. BMC Res Notes. 2010. PMID: 21083899 Free PMC article.

6

Available evidence and outcome of off-label use of rituximab in clinical practice.

Danés I, Agustí A, Vallano A, Martínez J, Alerany C, Ferrer A, López A, Cortés-Hernández J, Bosch JA. Danés I, et al. Among authors: agusti a. Eur J Clin Pharmacol. 2013 Sep;69(9):1689-99. doi: 10.1007/s00228-013-1518-4. Epub 2013 May 23. Eur J Clin Pharmacol. 2013. PMID: 23700188

7

Outcomes of off-label drug uses in hospitals: a multicentric prospective study.

Danés I, Agustí A, Vallano A, Alerany C, Martínez J, Bosch JA, Ferrer A, Gratacós L, Pérez A, Olmo M, Marron SM, Valderrama A, Bonafont X. Danés I, et al. Among authors: agusti a. Eur J Clin Pharmacol. 2014 Nov;70(11):1385-93. doi: 10.1007/s00228-014-1746-2. Epub 2014 Sep 9. Eur J Clin Pharmacol. 2014. PMID: 25196202 Free PMC article.

8

Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States.

Iglesias-López C, Agustí A, Obach M, Vallano A. Iglesias-López C, et al. Among authors: agusti a. Front Pharmacol. 2019 Aug 30;10:921. doi: 10.3389/fphar.2019.00921. eCollection 2019. Front Pharmacol. 2019. PMID: 31543814 Free PMC article.

9

Hurdles of environmental risk assessment procedures for advanced therapy medicinal products: comparison between the European Union and the United States.

Iglesias-Lopez C, Obach M, Vallano A, Agustí A, Montané J. Iglesias-Lopez C, et al. Among authors: agusti a. Crit Rev Toxicol. 2019 Aug;49(7):580-596. doi: 10.1080/10408444.2019.1689380. Epub 2019 Dec 17. Crit Rev Toxicol. 2019. PMID: 31846383 Review.

10

Corrigendum: Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States.

Iglesias-Lopez C, Agustí A, Obach M, Vallano A. Iglesias-Lopez C, et al. Among authors: agusti a. Front Pharmacol. 2020 May 25;11:766. doi: 10.3389/fphar.2020.00766. eCollection 2020. Front Pharmacol. 2020. PMID: 32523535 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

832 results

Search Page

Filters